Cargando…

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients

BACKGROUND: A new lung adenocarcinoma classification proposed by the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society (IASLC/ATS/ERS) has recently been published. This study aimed to investigate the utility of the new histological cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yan, Yu, Xinmin, Shi, Xun, Hong, Wei, Zhao, Jun, Shi, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067105/ https://www.ncbi.nlm.nih.gov/pubmed/24885205 http://dx.doi.org/10.1186/1477-7819-12-148

Ejemplares similares

Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma
por: Luo, Jizhuang, et al.
Publicado: (2016)

Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas
por: Yaldız, Demet, et al.
Publicado: (2019)

Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar‐predominant lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2021)

Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma
por: Li, Yan, et al.
Publicado: (2021)

Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma
por: Lin, Chun-Yu, et al.
Publicado: (2017)

Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma
por: Cao, Shuhui, et al.
Publicado: (2018)

Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification
por: Boukansa, Sara, et al.
Publicado: (2022)

Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients
por: Wang, Tengteng, et al.
Publicado: (2017)

Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma
por: Suda, Kenichi, et al.
Publicado: (2014)

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
por: Ding, Ying, et al.
Publicado: (2019)

Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma
por: Ito, Masaoki, et al.
Publicado: (2023)

Clinicopathologic characteristics and survival outcome in patients with advanced lung adenocarcinoma and KRAS mutation
por: Yang, Shifeng, et al.
Publicado: (2018)

cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma
por: He, Qiong, et al.
Publicado: (2020)

Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification
por: Hong, Jung Hee, et al.
Publicado: (2021)

Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014)

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype
por: Haltia, Ulla-Maija, et al.
Publicado: (2014)

Relationship of epidermal growth factor receptor activating mutations with histologic subtyping according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society 2011 adenocarcinoma classification and their impact on overall survival
por: Maturu, Venkata Nagarjuna, et al.
Publicado: (2016)

Deep learning for predicting subtype classification and survival of lung adenocarcinoma on computed tomography
por: Wang, Chengdi, et al.
Publicado: (2021)

Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma
por: Wang, Zeng, et al.
Publicado: (2017)

Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis
por: Xu, Congcong, et al.
Publicado: (2021)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
por: Cho, Jaeyoung, et al.
Publicado: (2016)

Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible
por: Kedia, Shiksha, et al.
Publicado: (2015)

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status
por: Isaka, Tetsuya, et al.
Publicado: (2022)

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma
por: Liu, Wei, et al.
Publicado: (2022)

Significance of histologic subtype size as a prognostic indicator in stage IA lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2023)

Controversies and challenges in the histologic subtyping of lung adenocarcinoma
por: Butnor, Kelly J.
Publicado: (2020)

Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma
por: Lu, Di, et al.
Publicado: (2020)

The clinical prognostic factors of patients with stage IB lung adenocarcinoma
por: Sui, Qihai, et al.
Publicado: (2021)

Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
por: Sun, Shuai, et al.
Publicado: (2022)

Operable gastric adenocarcinoma with different histological subtypes: Cancer-specific survival in the United States
por: Lin, Chun-Lin, et al.
Publicado: (2019)

Histologic subtype-based evaluation of recurrence and survival outcomes in patients with adenocarcinoma of the ampulla of Vater
por: Park, Se Jun, et al.
Publicado: (2023)

Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine
por: Wright, Gavin M., et al.
Publicado: (2014)

Different subtypes of EGFR exon19 mutation can affect prognosis of patients with non-small cell lung adenocarcinoma
por: Tian, Yingying, et al.
Publicado: (2018)

NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment
por: Koba, Hayato, et al.
Publicado: (2021)

Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
por: Hu, Haichuan, et al.
Publicado: (2014)

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients
por: Lu, Fangliang, et al.
Publicado: (2015)

Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer
por: Sheng, Hui, et al.
Publicado: (2019)

Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
por: Koh, Young Wha, et al.
Publicado: (2023)

Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status
por: Pak, Min Gyoung, et al.
Publicado: (2015)

Predominant Virulent IbA10G2 Subtype of Cryptosporidium hominis in Human Isolates in Barcelona: A Five-Year Study
por: Segura, Remedios, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2jr1ennscgf0laut1lst8e2q9i